why choose us

First received: February 27, 2023

Clinical Trial: Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Interstitial Lung Disease

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled, Multiple-dose Escalation Phase I Study of Genakumab for Injection in Chinese Healthy Adults

Brief Summary: To evaluate the safety and tolerability of multiple-dose subcutaneous injections of Genakumab for Injection in Chinese healthy adult volunteers.

Read more